Sagefield Capital’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Sagefield Capital’s Portfolio SRRA Stock Details SRRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-30,500	Closed	-$1.68M	–	178
2022 Q2	$1.68M	Buy	+30,500	New	+$1.6M	0.77%	27

Other funds holding SRRA

Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Sagefield Capital's SRRA Position: Q3 2022 in Review

Sagefield Capital sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 30,500 shares — an estimated $1.68M sold.

Sagefield Capital first reported a position in SRRA in Q2 2022 and held it in 1 quarter. The position peaked at $1.68M in Q2 2022. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.

Sagefield Capital reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Sagefield Capital sold 30,500 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $1.68M.
Sagefield Capital first reported a position in Sierra Oncology, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
Sagefield Capital's Sierra Oncology, Inc. Common Stock position peaked at $1.68M in Q2 2022.
1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.

Based on Sagefield Capital's 13F filing for Q3 2022, filed 14 Nov 2022.